Misplaced Pages

Xanthinol: Difference between revisions

Article snapshot taken from Wikipedia with creative commons attribution-sharealike license. Give it a read and then ask your questions in the chat. We can research this topic together.
Browse history interactively← Previous editContent deleted Content addedVisualWikitext
Revision as of 23:18, 24 August 2010 edit96.227.210.71 (talk)No edit summary← Previous edit Latest revision as of 03:11, 1 October 2022 edit undoHouseBlaster (talk | contribs)Edit filter managers, Administrators58,625 editsm Disambiguating links to Niacin (link changed to Niacin (substance)) using DisamAssist. 
(18 intermediate revisions by 16 users not shown)
Line 1: Line 1:
{{Short description|Chemical compound}}
{{Drugbox {{Drugbox
| Verifiedfields = changed
⚫ | IUPAC_name = 7--1,3-dimethylpurine-2,6-dione
| Watchedfields = changed
⚫ | image = Xanthinol.png
| verifiedrevid = 380810980
⚫ | CAS_number = 2530-97-4
⚫ | IUPAC_name = 7--1,3-dimethylpurine-2,6-dione
⚫ | ATC_prefix = none
⚫ | image = Xanthinol.png
⚫ | ATC_suffix =

⚫ | PubChem = 9913
<!--Clinical data-->
⚫ | DrugBank = 1
| tradename =
⚫ | C=13|H=21|N=5|O=4
⚫ | pregnancy_AU = <!-- A / B1 / B2 / B3 / C / D / X -->
| molecular_weight = 311.33 g/mol
| pregnancy_US = <!-- A / B / C / D / X -->
⚫ | bioavailability =
⚫ | pregnancy_category =
⚫ | protein_bound =
⚫ | legal_AU = <!-- S2, S3, S4, S5, S6, S7, S8, S9 or Unscheduled-->
| metabolism =
⚫ | legal_CA = <!-- Schedule I, II, III, IV, V, VI, VII, VIII -->
⚫ | elimination_half-life =
| excretion = | legal_UK = <!-- GSL, P, POM, CD, or Class A, B, C -->
| pregnancy_AU = <!-- A / B1 / B2 / B3 / C / D / X --> | legal_US = <!-- OTC / Rx-only / Schedule I, II, III, IV, V -->
| legal_status =
⚫ | pregnancy_US = <!-- A / B / C / D / X -->
⚫ | routes_of_administration =
⚫ | pregnancy_category=

⚫ | legal_AU = <!-- S2, S3, S4, S5, S6, S7, S8, S9 or Unscheduled-->
<!--Pharmacokinetic data-->
⚫ | legal_CA = <!-- Schedule I, II, III, IV, V, VI, VII, VIII -->
⚫ | bioavailability =
| legal_UK = <!-- GSL, P, POM, CD, or Class A, B, C -->
⚫ | protein_bound =
| legal_US = <!-- OTC / Rx-only / Schedule I, II, III, IV, V -->
| legal_status = | metabolism =
⚫ | elimination_half-life =
⚫ | routes_of_administration =
| excretion =

<!--Identifiers-->
| CAS_number_Ref = {{cascite|correct|??}}
⚫ | CAS_number = 2530-97-4
| UNII_Ref = {{fdacite|correct|FDA}}
| UNII = TN1B5910V2
⚫ | ATC_prefix = none
⚫ | ATC_suffix =
⚫ | PubChem = 9913
| ChemSpiderID_Ref = {{chemspidercite|changed|chemspider}}
| ChemSpiderID = 9526
| DrugBank_Ref = {{drugbankcite|correct|drugbank}}
⚫ | DrugBank = 1

<!--Chemical data-->
⚫ | C=13 | H=21 | N=5 | O=4
| smiles = O=C2N(c1ncn(c1C(=O)N2C)CC(O)CN(CCO)C)C
| StdInChI_Ref = {{stdinchicite|changed|chemspider}}
| StdInChI = 1S/C13H21N5O4/c1-15(4-5-19)6-9(20)7-18-8-14-11-10(18)12(21)17(3)13(22)16(11)2/h8-9,19-20H,4-7H2,1-3H3
| StdInChIKey_Ref = {{stdinchicite|changed|chemspider}}
| StdInChIKey = DSFGXPJYDCSWTA-UHFFFAOYSA-N
}} }}


'''Xanthinol''' is a drug prepared from ] used as a ].<ref>3-(Theophyllyl-7)-1-(N-methyl-N-hydroxyethyl)amino-2-propanol. Yokoyama, Matatsugu; Kawano, Shigeharu. (1963) Japanese Patent 38020588</ref> It is most often used as the ] with ] (nicotinic acid), known as ].<ref> at cancerweb.ncl.ac.uk</ref> '''Xanthinol''' is a drug prepared from ] used as a ].<ref>{{cite patent | title = 3-(Theophyllyl-7)-1-(N-methyl-N-hydroxyethyl)amino-2-propanol. | inventor = Yokoyama M, Kawano S | pubdate = 1963 | country = JA | number = 38020588 }}</ref><ref>{{cite book | vauthors = Morton IK, Hall JM |title=Concise dictionary of pharmacological agents : properties and synonyms |date=1999 |publisher=Kluwer Academic |location=Boston |isbn=978-0-7514-0499-9 |page=294}}</ref> It is most often used as the ] with ] (nicotinic acid), known as xanthinol nicotinate.<ref>{{cite web | url = http://cancerweb.ncl.ac.uk/cgi-bin/omd?xanthinol+niacinate | title = Xanthinol niacinate] | work = cancerweb.ncl.ac.uk }}</ref>


==References== ==References==
Line 34: Line 57:
] ]


{{cardiovascular-drug-stub}}

{{pharma-stub}}

Latest revision as of 03:11, 1 October 2022

Chemical compound Pharmaceutical compound
Xanthinol
Clinical data
ATC code
  • none
Identifiers
IUPAC name
  • 7--1,3-dimethylpurine-2,6-dione
CAS Number
PubChem CID
DrugBank
ChemSpider
UNII
CompTox Dashboard (EPA)
Chemical and physical data
FormulaC13H21N5O4
Molar mass311.342 g·mol
3D model (JSmol)
SMILES
  • O=C2N(c1ncn(c1C(=O)N2C)CC(O)CN(CCO)C)C
InChI
  • InChI=1S/C13H21N5O4/c1-15(4-5-19)6-9(20)7-18-8-14-11-10(18)12(21)17(3)13(22)16(11)2/h8-9,19-20H,4-7H2,1-3H3
  • Key:DSFGXPJYDCSWTA-UHFFFAOYSA-N
  (what is this?)  (verify)

Xanthinol is a drug prepared from theophylline used as a vasodilator. It is most often used as the salt with niacin (nicotinic acid), known as xanthinol nicotinate.

References

  1. JA 38020588, Yokoyama M, Kawano S, "3-(Theophyllyl-7)-1-(N-methyl-N-hydroxyethyl)amino-2-propanol.", published 1963 
  2. Morton IK, Hall JM (1999). Concise dictionary of pharmacological agents : properties and synonyms. Boston: Kluwer Academic. p. 294. ISBN 978-0-7514-0499-9.
  3. "Xanthinol niacinate]". cancerweb.ncl.ac.uk.
Stub icon

This drug article relating to the cardiovascular system is a stub. You can help Misplaced Pages by expanding it.

Categories: